Back to Journals » Therapeutics and Clinical Risk Management

Therapeutics and Clinical Risk Management


ISSN: 1178-203X

Editor-in-Chief: Professor Garry Walsh

ISSN 1176-6336 (Print) - went to online only in 2009

An international, peer-reviewed open access journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Extensive Radiological Manifestation in Patients with Diabetes and Pulmonary Tuberculosis: A Cross-Sectional Study

Zhan S, Juan X, Ren T, Wang Y, Fu L, Deng G, Zhang P

Therapeutics and Clinical Risk Management 2022, 18:595-602

Published Date: 23 May 2022

The Role of D-Dimers in the Initial Evaluation of COVID-19 [Response To Letter]

Baroiu L, Lese AC, Stefanopol IA, Iancu A, Dumitru C, Ciubara AB, Bujoreanu FC, Baroiu N, Ciubara A, Nechifor A, Anghel L, Tatu AL

Therapeutics and Clinical Risk Management 2022, 18:593-594

Published Date: 20 May 2022

Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China

Jiang J, Zhong W, Huang W, Gao Y, He Y, Li X, Liu Z, Zhou H, Fu Y, Liu R, Zhang W

Therapeutics and Clinical Risk Management 2022, 18:579-591

Published Date: 17 May 2022

 

Read more articles